Skip to main content
SpringerLink
Log in

Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas

  • Original Article
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Background

The impact of lymph node (LN) status and lymphadenectomy (LA) on survival in pancreatic neuroendocrine tumors (pNETs) remains controversial. We evaluated the impact of tumor extension and grade on nodal metastasis and survival.

Methods

Surgical pNET patients were queried in the Surveillance Epidemiology and End Results (SEER) database (1998–2012, N = 981). Factors associated with LN status were analyzed by logistic regression and by Cox analyses.

Results

For T1–T2 tumors, N status was associated only with tumor size. N status (p = 0.001), grade (p < 0.001), age (p = 0.001), and sex (p = 0.007) predicted overall survival (OS). For T3–T4, grade (p < 0.001), sex (p = 0.004), size (p = 0.013), and age (p = 0.007) but not N status (p = 0.789) predicted OS. For T1–T2, disease-specific survival (DSS; p = 0.003) and OS (p = 0.008) were longer for N0 vs N1, while N0 vs NX had similar OS (p = 0.59) and DSS (p = 0.80). While a difference was seen in DSS for NX vs N1 (p = 0.04), no significant difference in OS was seen (p = 0.08). For T3–T4, N status did not affect DSS (p = 0.365) or OS (p = 0.454). For all T groups and any N status, extended LA (≥10 nodes resected) was not associated with OS.

Conclusion

While in T1–T2 pNET N1 status is a predictor of negative OS, similar outcome between NX and N0 supports limited LN resection in selected patients. Extended LA is unlikely to be helpful in T3–T4.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. E. Sadot et al., Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control Study. Ann Surg Oncol, (Nov 23, 2015).

  2. L. R. McKenna, B. H. Edil, Update on pancreatic neuroendocrine tumors. Gland Surg 3, 258 (2014).

    PubMed  PubMed Central  Google Scholar 

  3. A. Frilling et al., Neuroendocrine tumor disease: an evolving landscape. Endocr Relat Cancer 19, R163 (2012).

    Article  CAS  PubMed  Google Scholar 

  4. I. M. Modlin et al., Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 9, 61 (2008).

    Article  CAS  PubMed  Google Scholar 

  5. T. C. Chua, T. X. Yang, A. J. Gill, J. S. Samra, Systematic Review and Meta-Analysis of Enucleation Versus Standardized Resection for Small Pancreatic Lesions. Ann Surg Oncol 23, 592 (2016).

    Article  PubMed  Google Scholar 

  6. E. Lermite et al., Complications after pancreatic resection: diagnosis, prevention and management. Clin Res Hepatol Gastroenterol 37, 230 (2013).

    Article  PubMed  Google Scholar 

  7. J. Wong et al., Predictors of lymph node metastases and impact on survival in resected pancreatic neuroendocrine tumors: a single-center experience. Am J Surg 208, 775 (2014).

    Article  PubMed  Google Scholar 

  8. S. M. Brunner et al., Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratification. BMC Surg 15, 49 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Y. M. Hashim et al., Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs). Ann Surg 259, 197 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  10. N. C. C. Network. (2016).

  11. J. R. Strosberg et al., Prognostic validity of a novel American Joint Committee on Cancer Staging Classification for pancreatic neuroendocrine tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 29, 3044 (2011).

    Article  Google Scholar 

  12. J. C. Yao et al., Population-based study of islet cell carcinoma. Annals of surgical oncology 14, 3492 (2007).

    Article  PubMed  PubMed Central  Google Scholar 

  13. A. B. Haynes et al., Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes. Arch Surg 146, 534 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  14. K. Y. Bilimoria et al., Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Ann Surg 247, 490 (2008).

    Article  PubMed  Google Scholar 

  15. J. R. Parekh et al., Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients. Pancreas 41, 840 (2012).

    Article  PubMed  Google Scholar 

  16. M. Falconi et al., Parenchyma-preserving resections for small nonfunctioning pancreatic endocrine tumors. Ann Surg Oncol 17, 1621 (2010).

    Article  PubMed  Google Scholar 

  17. E. J. Kuo, R. R. Salem, Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size. Ann Surg Oncol 20, 2815 (2013).

    Article  PubMed  Google Scholar 

  18. G. Kloppel, Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms. Endocr Relat Cancer 18 Suppl 1, S1 (Oct. 2011).

  19. J. E. Tepper et al., Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 19, 157 (2001).

    CAS  PubMed  Google Scholar 

  20. C. M. Huang et al., Prognostic impact of dissected lymph node count on patients with node-negative gastric cancer. World J Gastroenterol 15, 3926 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  21. J. Franko, W. Feng, L. Yip, E. Genovese, A. J. Moser, Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2,158 patients. J Gastrointest Surg 14, 541 (2010).

    Article  PubMed  Google Scholar 

  22. Q. D. Chu et al., Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the pancreas. Ann Surg Oncol 9, 855 (2002).

    Article  PubMed  Google Scholar 

  23. H. Ito et al., Surgery and staging of pancreatic neuroendocrine tumors: a 14-year experience. J Gastrointest Surg 14, 891 (2010).

    Article  PubMed  Google Scholar 

  24. R. Kumar et al., Role of (68)Ga-DOTATOC PET-CT in the diagnosis and staging of pancreatic neuroendocrine tumours. Eur Radiol 21, 2408 (2011).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, Section of Hepato-Pancreato-Biliary Surgery, The University of Texas MD Anderson Cancer Center, 1400 Pressler, Unit 1484, Houston, TX, 77030, USA

    Claudius Conrad, Jean-Nicolas Vauthey, Michael Kim, Jason B. Fleming, Matthew H. G. Katz & Jeffrey E. Lee

  2. Division of Gastrointestinal and Laparoscopic Surgery, Medical University of South Carolina, Charleston, SC, USA

    Onur C. Kutlu & David B. Adams

  3. Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Arvind Dasari

  4. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

    Jennifer A Chan

Authors
  1. Claudius Conrad
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Onur C. Kutlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Arvind Dasari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jennifer A Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jean-Nicolas Vauthey
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. David B. Adams
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Michael Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jason B. Fleming
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Matthew H. G. Katz
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jeffrey E. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claudius Conrad.

Ethics declarations

Funding Source

No external or internal funding was used.

Conflict of Interest

The authors declare that they have no conflict of interest.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

ESM 1

(PDF 116 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Conrad, C., Kutlu, O.C., Dasari, A. et al. Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas. J Gastrointest Surg 20, 1966–1974 (2016). https://doi.org/10.1007/s11605-016-3243-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-016-3243-7

Keywords

Search

Navigation